Skip to search formSkip to main contentSkip to account menu

Hyperlipidemia, Familial Combined

Known as: FCHL, Hyperlipidemias, Familial Combined, Multiple Lipoprotein-Type Hyperlipidemias 
A type of familial lipid metabolism disorder characterized by a variable pattern of elevated plasma CHOLESTEROL and/or TRIGLYCERIDES. Multiple genes… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2008
2008
Background: Our discovery in 2003 of the first mutations of PCSK9 gene causing autosomal dominant hypercholesterolaemia (ADH… 
Highly Cited
2003
Highly Cited
2003
OBJECTIVE Impaired glucose tolerance (IGT) has been associated with alterations in numerous coronary heart disease risk factors… 
Highly Cited
2002
Highly Cited
2002
The aim of the present study was to quantify intima-media thickness (IMT) in familial combined hyperlipidemia (FCHL) and to… 
Highly Cited
1998
Highly Cited
1998
OBJECTIVE To compare the lipid-lowering efficacies of simvastatin and gemfibrozil in NIDDM patients with combined (mixed… 
1996
1996
Tissue factor pathway inhibitor (TFPI), a kunitztype inhibitor of the extrinsic coagulation pathway, factor VII coagulant (FVIIc… 
Highly Cited
1994
Highly Cited
1994
Familial hypofibrinolysis with 3 generation, autosomal dominant, very high levels of plasminogen activator inhibitor activity… 
Highly Cited
1988
Highly Cited
1988
STUDY OBJECTIVE To compare the efficacy of gemfibrozil and colestipol with gemfibrozil and lovastatin in patients with familial… 
Highly Cited
1983
Highly Cited
1983
Hyperapobetalipoproteinemia is defined as the combination of a normal low density lipoprotein (LDL) cholesterol in the face of an…